Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

US58506Q1094
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG0065B7K59
MEDP
Medpace Holdings Inc
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Diagnostics & Research · THEMEFOLIO: $HLTH
NAME
Medpace Holdings Inc
ISIN
US58506Q1094
TICKER
MEDP
MIC
XNAS
REUTERS
MEDP.OQ
BLOOMBERG
MEDP US
Wed, 27.05.2026       Medpace
US58506Q1094

NEW YORK, May 26, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Cl...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 26.05.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 26.05.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - May 26, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpace...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 26.05.2026       Medpace
US58506Q1094

SAN DIEGO, May 26, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), have until Monday, June 8, 2026 to seek appointment as lead plaintiff of the Medpace class action lawsu...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 26.05.2026       Medpace
US58506Q1094

NEW YORK, May 26, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Medpace Holdings, Inc. (NASDAQ: MEDP). Shareholders who purchased shares of MEDP during the class period listed are encouraged to...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 26.05.2026       Medpace
US58506Q1094

Medpace Holdings Inc. faces securities fraud allegations for alleged understatement of cancellation rates and overstatement of book-to-bill ratio, causing a 16% single day stock drop; investors urged to act by June 8, 2026.NEW YORK, May 26, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class actio...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Mon, 25.05.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - May 24, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpace...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Sun, 24.05.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - May 24, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Medpace Holdings, Inc. (NASDAQ: MEDP) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Sun, 24.05.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Sun, 24.05.2026       Medpace
US58506Q1094

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, inclusive (the “Class Period”), have until Monday, June 8, 2026 to seek appointment as lead plaintiff of the Medpace class action lawsuit. Captioned Durbin v. M...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Sat, 23.05.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 22.05.2026       Medpace
US58506Q1094

LOS ANGELES, May 22, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP)....
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 22.05.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 21.05.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - May 21, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Me...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 21.05.2026       Medpace
US58506Q1094

NEW YORK, May 21, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 21.05.2026       Medpace
US58506Q1094

Time-Sensitive: Allegations Focus on Misrepresentations About Backlog Cancellation BehaviorNEW YORK, May 21, 2026 /PRNewswire/ -- SueWallSt alerts investors in Medpace Holdings Inc. (NASDAQ: MEDP) that a pending securities class action has been filed on behalf of shareholders who purchased securities between April 22, 2025 and February 9, 2026....
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 21.05.2026       Medpace
US58506Q1094

NEW YORK, May 20, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Cl...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 20.05.2026       Medpace
US58506Q1094

BENSALEM, Pa., May 20, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN MEDPACE HOLDINGS, INC. (MEDP), C...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 20.05.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - May 20, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Medpace Holdings, Inc. (NASDAQ: MEDP) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 20.05.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - May 19, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpace...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Tue, 19.05.2026       Medpace
US58506Q1094

NEW YORK, May 19, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Medpace Holdings, Inc. (NASDAQ: MEDP). Shareholders who purchased shares of MEDP during the class period listed are encouraged to...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 19.05.2026       Medpace
US58506Q1094

Medpace Holdings Inc. faces securities fraud allegations for alleged understatement of cancellation rates and overstatement of book-to-bill ratio, causing a 16% single day stock drop; investors urged to act by June 8, 2026.NEW YORK, May 19, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class actio...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 19.05.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - May 18, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpace...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 19.05.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Sat, 16.05.2026       Medpace
US58506Q1094

SAN DIEGO, May 15, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, both dates inclusive (the "Class Period"), have until Monday, June 8, 2026 to seek appointment as lead plaintiff of the Medpace class a...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 15.05.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - May 15, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Medpace Holdings, Inc. (NASDAQ: MEDP) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 15.05.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 15.05.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - May 14, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpace...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 15.05.2026       Medpace
US58506Q1094

NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail a...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 14.05.2026       Medpace
US58506Q1094

LOS ANGELES, May 14, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP) have opportunity to lead the securities fraud class action lawsuit....
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 14.05.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner J...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 14.05.2026       Medpace
US58506Q1094

LOS ANGELES, May 14, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Sharehold...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 14.05.2026       Medpace
US58506Q1094

LOS ANGELES, May 14, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 13.05.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - May 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpace...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 13.05.2026       Medpace
US58506Q1094

Promise vs. Reality: The Medpace Performance GapNEW YORK, May 13, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP highlights the contrast between Medpace Holdings Inc.'s (NASDAQ: MEDP) promises and results. Find out if you can recover your investment losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500....
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 13.05.2026       Medpace
US58506Q1094

NEW YORK, May 13, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Cl...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 12.05.2026       Medpace
US58506Q1094

Levi & Korsinsky, LLP alerts investors in Medpace Holdings Inc. (NASDAQ: MEDP) of a pending securities class action naming senior executives as individual defendants. Class Period: April 22, 2025 through February 9, 2026. Find out if you qualify to recover losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com | (212) 363-7500.Medpac...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 12.05.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - May 12, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Medpace Holdings, Inc. (NASDAQ: MEDP) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 12.05.2026       Medpace
US58506Q1094

NEW YORK, May 12, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Medpace Holdings, Inc. (NASDAQ: MEDP). Shareholders who purchased shares of MEDP during the class period listed are encouraged to...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 12.05.2026       Medpace
US58506Q1094

San Diego, California--(Newsfile Corp. - May 12, 2026) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, both dates inclusive (the "Class Period"), have until Monday, June 8, 2026 to seek appointment as lead plaintiff of the...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 12.05.2026       Medpace
US58506Q1094

Medpace Holdings Inc. faces securities fraud allegations for alleged understatement of cancellation rates and overstatement of book-to-bill ratio, causing a 16% single day stock drop; investors urged to act by June 8, 2026.NEW YORK, May 12, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class actio...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 12.05.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - May 11, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpace...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 12.05.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Mon, 11.05.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - May 10, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpace...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Sun, 10.05.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - May 9, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpace...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Sat, 09.05.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Sat, 09.05.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - May 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpace...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 08.05.2026       Medpace
US58506Q1094

LOS ANGELES, May 8, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP)....
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 08.05.2026       Medpace
US58506Q1094

NEW YORK, May 7, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Cla...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 08.05.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - May 7, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpace...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink